InvestorsHub Logo
Followers 16
Posts 4513
Boards Moderated 0
Alias Born 01/31/2011

Re: None

Friday, 12/15/2017 8:22:00 AM

Friday, December 15, 2017 8:22:00 AM

Post# of 46104
Look at the all the international distributors signing on to sell Synavax. The distributors buy product and then resell this product. That is in addition to the sales in the US. Even though INTK's staff is lean and mean (translates into lower overhead, higher profitability), this provides INTK great worldwide exposure.

INTK has limited themselves to six different products which helps the turnaround situation. They can focus on these and not be "all things to all people".

Because of a combination of everyone waiting for an update, tax loss selling and thin bids, it may be giving an opportunity to purchase at unreasonably low stock prices.

I say "may" because it is up to the individual shareholder to due current due diligence and invest only what they can risk.

GLTA